Ken Redekop
Ken Redekop
Verified email at
Cited by
Cited by
Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
Columbus Investigators
New England Journal of Medicine 337 (10), 657-662, 1997
Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes
WK Redekop, MA Koopmanschap, RP Stolk, GEHM Rutten, ...
Diabetes care 25 (3), 458-463, 2002
The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis
P Swart, BWJ Mol, F van der Veen, M van Beurden, WK Redekop, ...
Fertility and sterility 64 (3), 486-491, 1995
The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations
WBF Brouwer, NJA Van Exel, B Van Gorp, WK Redekop
Quality of Life Research 15 (6), 1005-1021, 2006
Trigeminal neuralgia in multiple sclerosis
JP Hooge, WK Redekop
Neurology 45 (7), 1294-1296, 1995
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon
TI Verhoef, G Ragia, A de Boer, R Barallon, G Kolovou, V Kolovou, ...
New England Journal of Medicine 369 (24), 2304-2312, 2013
Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis
MM Ortegon, WK Redekop, LW Niessen
Diabetes care 27 (4), 901-907, 2004
Comparing methodologies for the cost estimation of hospital services
SS Tan, FFH Rutten, BM Van Ineveld, WK Redekop, ...
The European Journal of Health Economics 10 (1), 39-45, 2009
Contrast-enhanced ultrasound using SonoVue®(sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance …
M Westwood, M Joore, J Grutters, K Redekop, N Armstrong, K Lee, V Gloy, ...
Health technology assessment (Winchester, England) 17 (16), 1, 2013
Biofeedback training in treatment of childhood constipation: a randomised controlled study
RN Van der Plas, MA Benninga, HA Büller, PM Bossuyt, LMA Akkermans, ...
The Lancet 348 (9030), 776-780, 1996
The faces of personalized medicine: a framework for understanding its meaning and scope
WK Redekop, D Mladsi
Value in Health 16 (6), S4-S9, 2013
Predicting mortality in intensive care patients with acute renal failure treated with dialysis.
CE Douma, WK Redekop, JH Van Der Meulen, RW Van Olden, J Haeck, ...
Journal of the American Society of Nephrology 8 (1), 111-117, 1997
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design
RMF Van Schie, MIA Wadelius, F Kamali, AK Daly, VG Manolopoulos, ...
Pharmacogenomics 10 (10), 1687-1695, 2009
Pharmacogenetic‐guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
TI Verhoef, WK Redekop, AK Daly, RMF Van Schie, A De Boer, ...
British journal of clinical pharmacology 77 (4), 626-641, 2014
Randomised trial of biofeedback training for encopresis.
RN Van der Plas, MA Benninga, WK Redekop, JA Taminiau, HA Büller
Archives of disease in childhood 75 (5), 367-374, 1996
Blood pressure patterns in rural, semi-urban and urban children in the Ashanti region of Ghana, West Africa
C Agyemang, WK Redekop, E Owusu-Dabo, MA Bruijnzeels
BMC Public Health 5 (1), 1-7, 2005
Late onset polio sequelae: disabilities and handicaps in a population-based cohort of the 1956 poliomyelitis outbreak in The Netherlands
B Ivanyi, F Nollet, WK Redekop, R de Haan, M Wohlgemuht, ...
Archives of physical medicine and rehabilitation 80 (6), 687-690, 1999
A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction
AM Van Berkel, C Boland, WK Redekop, J Bergman, AK Groen, ...
Endoscopy 30 (08), 681-686, 1998
Quality of life of patients with type I diabetes mellitus
HE Hart, HJG Bilo, WK Redekop, RP Stolk, JH Assink, ...
Quality of life research 12 (8), 1089-1097, 2003
The cost effectiveness of Apligraf® treatment of diabetic foot ulcers
WK Redekop, J McDonnell, P Verboom, K Lovas, Z Kalo
Pharmacoeconomics 21 (16), 1171-1183, 2003
The system can't perform the operation now. Try again later.
Articles 1–20